Masimo Corporation (LON:0JZ2)
London · Delayed Price · Currency is GBP · Price in USD 145.97
+3.78 (2.66%)
At close: Sep 5, 2025
Masimo Market Cap
Masimo has a market cap or net worth of 5.91 billion as of September 5, 2025. Its market cap has increased by 18.82% in one year.
Market Cap
5.91B
Enterprise Value
6.27B
Revenue
1.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
145.97
Market Cap Chart
Since August 8, 2007, Masimo's market cap has increased from 541.95M to 5.91B, an increase of 990.39%. That is a compound annual growth rate of 14.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 5.91B | -16.41% |
| Dec 31, 2024 | 7.07B | 45.39% |
| Dec 29, 2023 | 4.86B | -24.67% |
| Dec 30, 2022 | 6.45B | -45.94% |
| Dec 31, 2021 | 11.94B | 10.33% |
| Dec 31, 2020 | 10.82B | 69.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 187.48B |
| GSK plc | 59.44B |
| Haleon | 32.74B |
| Smith & Nephew | 12.30B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.81B |
| HUTCHMED (China) | 2.01B |
| Genus | 1.76B |